Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

Summary

This is a single center, open-label study to evaluate the efficacy of AKCEA-ANGPTL3- LRX for reduction of low density lipoprotein cholesterol (LDL-C) levels in patients with Homozygous Familial Hypercholesterolemia (HoFH).

Timeline

Start

2018-04-12

Primary completion

2018-09-30

Completion

2018-12-31

Outcome

Outcome not reported

Stopped: “Study withdrawn due to lack of available patients meeting entry criteria”

Drugs

Indications